Literature DB >> 12209032

Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.

E Larsson1, H Erlandsson Harris, J C Lorentzen, A Larsson, B Månsson, L Klareskog, T Saxne.   

Abstract

OBJECTIVES: We investigated if changes in serum/plasma fibrinogen (FIB), hyaluronan (HA) and cartilage oligomeric matrix protein (COMP) levels can be used to differentiate between inflammation and cartilage involvement during arthritis.
METHODS: Collagen-induced arthritis (CIA), oil-induced arthritis (OIA) and for comparison, experimental autoimmune encephalitis (EAE) induced in DA rats were investigated.
RESULTS: Elevations of FIB concentrations were apparent at days 4-7 post-immunization in both arthritis models reaching a maximum on day 20-21, i.e. before peak arthritis. Elevations of HA in both models were seen shortly before macroscopically apparent arthritis, and peaked at or just before maximal arthritis, i.e. later in CIA than in OIA. COMP levels increased only after onset of arthritis and peaked late in disease (days 34-37), being significantly higher in the more destructive CIA compared with the less destructive OIA. During EAE flares, only FIB levels increased.
CONCLUSIONS: FIB is a general inflammation marker, HA appears to be a marker for synovitis and changes in COMP levels appear to reflect the cartilage destruction process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209032     DOI: 10.1093/rheumatology/41.9.996

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.

Authors:  M L E Andersson; I F Petersson; K E Karlsson; E N Jonsson; B Månsson; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

2.  Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.

Authors:  L Senolt; M Braun; M Olejárová; S Forejtová; J Gatterová; K Pavelka
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

3.  Prognostic laboratory markers of joint damage in rheumatoid arthritis.

Authors:  E Lindqvist; K Eberhardt; K Bendtzen; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

4.  Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.

Authors:  Caroline Jochems; Ulrika Islander; Malin Erlandsson; Margareta Verdrengh; Claes Ohlsson; Hans Carlsten
Journal:  Arthritis Res Ther       Date:  2005-04-27       Impact factor: 5.156

5.  Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis.

Authors:  Maria L E Andersson; Carina A Thorstensson; Ewa M Roos; Ingemar F Petersson; Dick Heinegård; Tore Saxne
Journal:  BMC Musculoskelet Disord       Date:  2006-12-07       Impact factor: 2.362

6.  Therapeutic efficacy of vitamin E δ-tocotrienol in collagen-induced rat model of arthritis.

Authors:  Nagaraja Haleagrahara; Mirashini Swaminathan; Srikumar Chakravarthi; Ammu Radhakrishnan
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

7.  Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Authors:  Maria L E Andersson; Björn Svensson; Ingemar F Petersson; Ingiäld Hafström; Kristina Albertsson; Kristina Forslind; Dick Heinegård; Tore Saxne
Journal:  BMC Musculoskelet Disord       Date:  2013-08-02       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.